Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Developmental Disabilities

• Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
• Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
• Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities
• A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
• Use of Hyperpolarized 129Xe MR Lung Imaging in Infants
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
• Neuroimaging GABA Physiology in Fragile X Syndrome
• Propranolol for Challenging Behaviors in Autism
• Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children
• A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder
• Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
• Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants
• An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
• Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
• An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
• An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
• Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
• Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
• Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
• Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
• Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities
• Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders
• D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
• Memantine in Adult Autism Spectrum Disorder
• Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
• Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
• Methylphenidate Study in Young Children With Developmental Disorders
• Treatment Strategies for Children With Smith-Magenis Syndrome
• A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
• Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
• Mercury Chelation to Treat Autism
• Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism
• Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
• An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders
• A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
• Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD)
• Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)
• Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
• RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
• Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
• Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders